Diabetes and HCV | January 24, 2024
Date of Presentation: January 24, 2024
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #diabetes #dm #hcc #hcv and diabetes #hepatitis c #hepatocellular carcinoma #type 2 diabetes
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV & insulin resistance, how HCV can potentially induce or aggravate diabetes and what to be aware of when caring for a patient with diabetes who is undergoing treatment for HCV. She also discusses what to expect for patients with diabetes post-HCV elimination and risk factors for hepatocellular carcinoma (HCC).
Recording:
Presented by:
Mary Carol Greenlee, MD, FACP, FACE
Mary Carol Greenlee, MD, MACP, is board certified in internal medicine and in endocrinology, diabetes, and metabolism with over 30 years’ experience in private practice. Dr. Greenlee graduated Summa Cum Laude from Miami University (Ohio) and with Highest Distinction from Indiana University School of Medicine. She did her internal medicine internship and residency at Ball Memorial Hospital in Muncie, IN before returning to IU Medical Center for her fellowship in endocrinology. Carol chaired the “AID” project to develop shared decision-making tools for insulin therapy, as well as several workgroups focused on improving care coordination between primary and specialty care. She received NCQA recognition for Patient-Centered Specialty Care in 2014 and the Endocrine Society award for Outstanding Clinical Practitioner in 2016.
Resources Provided:
Date added: January 20, 2024